Cutaneous and Ganglion Sarcoidosis Induced by Polycaprolactone Facial Filler: A New Expression of ASIA Syndrome?

Juan Ortiz-Álvarez,Jose Antonio Lebrón-Martín,Lourdes Rodríguez Fernández-Freire,Teresa Zulueta Dorado,José Salvador García Morillo,Jose Antonio Lebron-Martin,Lourdes Rodriguez Fernandez-Freire,Teresa Zulueta-Dorado,Jose Salvador Garcia-Morillo
DOI: https://doi.org/10.12890/2021_002652
2021-06-09
European Journal of Case Reports in Internal Medicine
Abstract:Dermal fillers are applied using a minimally invasive technique with a good safety profile. However, they can have side effects. We present the case of a patient who, 2 months after undergoing polycaprolactone (Ellansé®) injections, developed nodular facial and nodal lesions that were compatible with sarcoidosis on histology. This complication has not been previously described for polycaprolactone and could be the expression of an autoimmune syndrome induced by adjuvants.
What problem does this paper attempt to address?